Notice2024-00162
Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board, Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 8, 2024
Issuing agencies
Veterans Affairs Department
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 5 (Monday, January 8, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 5 (Monday, January 8, 2024)]
[Notices]
[Page 987]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-00162]
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Joint Biomedical Laboratory Research and Development and Clinical
Science Research and Development Services Scientific Merit Review
Board, Notice of Meeting
The Department of Veterans Affairs (VA) gives notice under the
Federal Advisory Committee Act, 5 U.S.C. ch.10, that a meeting of the
Joint Biomedical Laboratory Research and Development and Clinical
Science Research and Development Services Scientific Merit Review Board
will be held January 30, 2024, via Webex. The meeting will be held
between 3 p.m. and 5 p.m. EDT. The meeting will be closed to the public
from 3:30-5 p.m. EDT for the discussion, examination and reference to
the research applications and scientific review. Discussions will
involve reference to staff and consultant critiques of research
proposals. Discussions will deal with scientific merit of each proposal
and qualifications of personnel conducting the studies, the disclosure
of which would constitute a clearly unwarranted invasion of personal
privacy. Additionally, premature disclosure of research information
could significantly obstruct implementation of proposed agency action
regarding the research proposals. As provided by Public Law 92-463
subsection 10(d), as amended by Public Law 94-409, closing the
committee meeting is in accordance with 5 U.S.C. 552b(c) (6) and
(9)(B).
The objective of the Board is to provide for the fair and equitable
selection of the most meritorious research projects for support by VA
research funds and to offer advice for research program officials on
program priorities and policies. The ultimate objective of the Board is
to ensure the high quality and mission relevance of VA's legislatively
mandated Biomedical Laboratory and Clinical Science Research and
Development programs.
Board members advise the Directors of the Biomedical Laboratory and
Clinical Sciences Research Services and the Chief Research and
Development Officer on the scientific and technical merit, the mission
relevance, and the protection of human subjects of Biomedical
Laboratory and Clinical Sciences Research and Development proposals.
The Board does not consider grants, contracts, or other forms of
extramural research.
Members of the public may attend the open portion of the meeting.
The time limited agenda does not enable public comments or
presentations. To attend the open portion of the meeting (3-3:30 p.m.
EDT), the public may join by dialing the phone number 1-404-397-1596
and entering the meeting number (access code): 2763 451 0764.
Written public comments must be sent to Michael R. Burgio, Ph.D.,
Designated Federal Officer, Office of Research and Development,
Department of Veterans Affairs (14RD), 810 Vermont Avenue NW,
Washington, DC 20420, or to <a href="/cdn-cgi/l/email-protection#733e1a101b12161f5d310601141a1c3305125d141c05"><span class="__cf_email__" data-cfemail="95d8fcf6fdf4f0f9bbd7e0e7f2fcfad5e3f4bbf2fae3">[email protected]</span></a> at least five days
before the meeting via the email listed above. The written public
comments will be shared with the board members. The public may not
attend the closed portion of the meeting as disclosure of research
information could significantly obstruct implementation of proposed
agency action regarding the research proposals (Pub. L. 92-463
subsection 10(d), as amended by Pub. L. 94-409, closing the committee
meeting is in accordance with title 5 U.S.C. 552b(c)(6) and (9)(B).
Dated: January 3, 2024.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2024-00162 Filed 1-5-24; 8:45 am]
BILLING CODE P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 8, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.